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In the title compound, C10H9N3, the benzimidazol-2-amine
and CH2—C CH units are not coplanar, with a dihedral
angle of 60.36  between their mean planes. The crystal
structure is stabilized by intermolecular N—H   N hydrogen
bonding and  –  interactions [centroid–centroid distances
3.677 (1) and 3.580 (1) A ˚ ], assembling the molecules into a
supramolecular structure with a three-dimensional network.
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de Dios et al. (2005). For polyfunctionality and antiviral
activity of 2-aminobenzimidazoles, see: Garuti & Roberti
(2002); Andries et al. (2003). For antiproliferative properties,
see: Garuti et al. (1998); Nawrocka et al. (2005). For inhibition
activity against various strains of bacteria, fungi and yeasts,
see: Nofal et al. (2002); Omar et al. (1996); Del Poenta et al.
(1999). For structural analysis of small molecules, see: Singh,
Agarwal, Mahawar & Awasthi (2011); Singh, Singh et al.
(2011); Singh, Agarwal & Awasthi (2011); Agarwal et al.
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Tmin = 0.677, Tmax = 1.000
9853 measured reﬂections
3178 independent reﬂections











H atoms treated by a mixture of
independent and constrained
reﬁnement
 max = 0.25 e A ˚  3
 min =  0.18 e A ˚  3
Table 1
Hydrogen-bond geometry (A ˚ ,  ).
D—H   AD —H H   AD    AD —H   A
N3—H1N3   N1
i 0.90 (2) 2.36 (2) 3.1823 (18) 153.5 (18)
N3—H2N3   N1
ii 0.860 (18) 2.241 (19) 3.0591 (15) 158.6 (15)
Symmetry codes: (i)  x þ 1; y; z þ 2; (ii) x; y;z   1
2.
Data collection: CrysAlis PRO (Oxford Diffraction, 2009); cell
reﬁnement: CrysAlis PRO; data reduction: CrysAlis PRO;
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008);
program(s) used to reﬁne structure: SHELXL97 (Sheldrick, 2008);
molecular graphics: Mercury (Macrae et al., 2006); software used to
prepare material for publication: publCIF (Westrip, 2010).
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1-Prop-2-ynyl-1H-benzimidazol-2-amine
A. Agarwal, M. K. Singh and S. K. Awasthi
Comment
The 2-aminobenzimidazole compounds showed different biological activities such as immunotropic, diuretic, antihistamine
as well as highly selective p38a MAP inhibition properties ( Nawrocka et al., 1999, Cuberens & Contijoch 1997, Mor et
al., 2004, De Dios et al., 2005). The polyfunctionality of the 2-aminobenzimidazole molecule is due to the cyclic guanidine
moiety which acts as a building block for the synthesis of a large number of benzimidazole derivatives. The various benzim-
idazole derivatives such as enviradene and enviroxime and other 2-aminobenzimidazole derivatives have been synthesized
and screened for antiviral activity (Garuti & Roberti 2002, Andries et al., 2003). Moreover, a number of 2-aminobenzim-
idazoles have exhibited antiproliferative properties (Garuti, Varoli et al., 1998, Nawrocka et al., 2005). Further, different
substituted 2-aminobenzimidazoles have been found to possess inhibition activity against various strains of bacteria, fungi
and yeasts in vivo and in vitro ( Nofal et al., 2002, Omar et al., 1996, Del Poenta et al., 1999). In continuation with our
recent work on structural analysis of small molecule (Singh, Agarwal, Mahawar & Awasthi 2011, Singh, Singh, Agarwal,
Hussain & Awasthi 2011, Singh, Agarwal & Awasthi 2011, Agarwal et al., 2011), we wish to report here the crystal structure
of 1-prop-2-ynyl-1H-benzimidazol-2-ylamine (Figure1).
In the title compound, the C7-N3 single bond length (1.35 Å) is shorter than normal C-N (1.47 Å) bond suggesting
a delocalized double bond in benzimidazole moiety. Again, in the crystal structure, the title compound is stabilized by
intermolecular N-H···N hydrogen bonding and π···π interaction assembling, thus forming into supramolecule type assembly
with a tri-dimensional network (Figure 2, Table 1). π···π interactions form a dimer, the ring A and B of an benzimidazole
skeleton stacks with the ring B and A of another adjacent benzimidazole skeleton, respectively. The distance of CgA and
CgB is 3.641 Å, where CgA and CgB are the center of ring A and B, respectively and the centroid - centroid distance between
two adjacent benzimidazole ring is 3.580 Å and the bond distance between atoms C5···C10 is found to be 3.282 Å as well
as the bond distance between atoms C1···C5 is found to be 3.369 Å, which helps in overall crystal structure packing as well
as stabilization (Figure 2). In the molecule, 2-aminobenzimidazole ring and CH2-C≡CH are non-planar with dihedral angle
is 60.36. The CCDC No. of crystal is 843876.
Experimental
The synthesis of the title compound was carried out according to the published procedure (Lilienkampf et al., 2009). Briefly,
to a solution of 2- aminobenzimidazole (0.50 g m, 3.76 mmol) in dry acetone was added anhydrous K2CO3 (3.112 g m,
22.55 mmol) and reaction mixture was further refluxed for 15–30 minutes. Subsequently, KI (0.312 g m, 1.88 mmol) and
propargyl bromide (0.39 ml, 4.37 mmol) were added into it and further refluxed the reaction mixture for 18 hrs. After this
period, the reaction mixture was cooled, filtered and the filtrate was concentrated invacuo up to 10 ml and left for few days
at room temperature which gave transparent crystals after slow evaporation of solvent. Yield = 30%, MS (Macromass G)
m/z = 188 (M+), Rf0.59 (98:2, CH2Cl2: MeOH) Elemental analysis (Perkin –Elmer 240°C elemental analyzer)Calculatedsupplementary materials
sup-2
for: C10 H9 N3(%) C– 70.2, H-5.3, N -24.5 found C-69.9, H-5.5, N -24.6. 1H NMR (CDCl3), 7.71–7.68 (m, 1H), 7.44–7.42
(m, 1H), 7.26–7.21 (m, 1H), 7.07–7.02 (m, 1H), 4.88 (s, 2H, NH2), 4.71 (s, 2H, CH2), 2.43 (s, 1H, CH).
Refinement
All H atoms were located from difference Fourier map (range of C—H = 0.93 - 0.97 Å and N—H = 0.86 (18) - 0.90 (2)
Å) and allowed to refine freely.
Figures
Fig. 1. ORTEP diagram of the molecule with thermal ellipsoids drawn at 50% probability
level Color code: White: C; blue: N; white: H.
Fig. 2. Packing diagram of molecule viewed through a plane showing supramolecule arrange-
ment and intermolecular N—H···N (red and purple doted line) hydrogen bonding, C—H···C
(Green doted line) interactions and π···π (magneta and light blue doted line) interaction.
Fig. 3. The synthesis of the title compound.
1-Prop-2-ynyl-1H-benzimidazol-2-amine
Crystal data
C10H9N3 F(000) = 720.0
Mr = 171.20 Dx = 1.293 Mg m−3
Monoclinic, C2/c Mo Kα radiation, λ = 0.71073 Å
Hall symbol: -C 2yc Cell parameters from 2285 reflections
a = 15.385 (2) Å θ = 3.3–29.2°
b = 12.1433 (12) Å µ = 0.08 mm−1
c = 9.4653 (10) Å T = 293 K
β = 95.755 (11)° Block, clear white
V = 1759.5 (3) Å3 0.39 × 0.36 × 0.20 mm
Z = 8
Data collection
Oxford Diffraction Xcalibur Sapphire3
diffractometer
3178 independent reflections
Radiation source: fine-focus sealed tube 2505 reflections with I > 2σ(I)supplementary materials
sup-3
graphite Rint = 0.020
ω scans θmax = 32.5°, θmin = 3.0°
Absorption correction: multi-scan
(CrysAlis PRO; Oxford Diffraction, 2009)
h = −19→23
Tmin = 0.677, Tmax = 1.000 k = −18→18
9853 measured reflections l = −13→14
Refinement
Refinement on F2 Primary atom site location: structure-invariant direct
methods
Least-squares matrix: full Secondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.054
Hydrogen site location: inferred from neighbouring
sites
wR(F2) = 0.137




2) + (0.0598P)2 + 0.678P]
where P = (Fo
2 + 2Fc
2)/3
3178 reflections (Δ/σ)max = 0.006
126 parameters Δρmax = 0.25 e Å−3
0 restraints Δρmin = −0.18 e Å−3
Special details
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance mat-
rix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations
between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of
cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, convention-
al R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-
factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large
as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x y z Uiso*/Ueq
H2N3 0.4017 (11) −0.0261 (14) 0.750 (2) 0.056 (5)*
H1N3 0.4441 (14) −0.0599 (17) 0.892 (2) 0.082 (6)*
N2 0.35287 (7) 0.16350 (8) 0.82062 (9) 0.0344 (2)
N1 0.40855 (7) 0.10067 (8) 1.03481 (10) 0.0370 (2)
C5 0.38413 (7) 0.21017 (9) 1.04715 (11) 0.0327 (2)
C7 0.38975 (8) 0.07726 (9) 0.89807 (11) 0.0347 (2)
N3 0.40152 (10) −0.02285 (9) 0.84084 (12) 0.0507 (3)
C6 0.34953 (7) 0.25096 (9) 0.91465 (11) 0.0332 (2)
C4 0.39113 (9) 0.27854 (11) 1.16533 (13) 0.0416 (3)
H4 0.4128 0.2525 1.2544 0.050*
C9 0.38623 (9) 0.24521 (11) 0.60031 (12) 0.0446 (3)supplementary materials
sup-4
C3 0.36468 (10) 0.38702 (11) 1.14576 (15) 0.0495 (3)
H3 0.3700 0.4350 1.2227 0.059*
C8 0.32884 (9) 0.16969 (11) 0.66794 (12) 0.0448 (3)
H8A 0.2689 0.1947 0.6500 0.054*
H8B 0.3326 0.0969 0.6268 0.054*
C1 0.32143 (9) 0.35828 (10) 0.89445 (15) 0.0439 (3)
H1 0.2979 0.3839 0.8062 0.053*
C2 0.33019 (10) 0.42580 (10) 1.01311 (17) 0.0508 (3)
H2 0.3126 0.4989 1.0040 0.061*
C10 0.43272 (11) 0.30823 (14) 0.55223 (17) 0.0580 (4)
H10 0.4697 0.3583 0.5140 0.070*
Atomic displacement parameters (Å2)
U11 U22 U33 U12 U13 U23
N2 0.0425 (5) 0.0342 (5) 0.0259 (4) 0.0015 (4) 0.0010 (3) 0.0029 (3)
N1 0.0490 (6) 0.0362 (5) 0.0257 (4) 0.0108 (4) 0.0030 (4) 0.0004 (3)
C5 0.0345 (5) 0.0338 (5) 0.0301 (5) 0.0030 (4) 0.0054 (4) 0.0003 (4)
C7 0.0417 (6) 0.0349 (5) 0.0277 (5) 0.0055 (4) 0.0048 (4) 0.0016 (4)
N3 0.0769 (9) 0.0425 (6) 0.0319 (5) 0.0186 (6) 0.0013 (5) −0.0051 (4)
C6 0.0347 (5) 0.0322 (5) 0.0331 (5) −0.0005 (4) 0.0051 (4) 0.0026 (4)
C4 0.0477 (7) 0.0439 (6) 0.0336 (5) 0.0033 (5) 0.0055 (5) −0.0059 (5)
C9 0.0586 (8) 0.0469 (7) 0.0289 (5) 0.0108 (6) 0.0069 (5) 0.0047 (5)
C3 0.0562 (8) 0.0403 (6) 0.0534 (8) 0.0005 (5) 0.0118 (6) −0.0139 (6)
C8 0.0554 (8) 0.0482 (7) 0.0289 (5) −0.0018 (6) −0.0051 (5) 0.0047 (5)
C1 0.0481 (7) 0.0341 (5) 0.0491 (7) 0.0021 (5) 0.0029 (5) 0.0077 (5)
C2 0.0554 (8) 0.0308 (5) 0.0669 (9) 0.0035 (5) 0.0099 (7) −0.0020 (6)
C10 0.0669 (10) 0.0587 (8) 0.0513 (8) 0.0076 (7) 0.0205 (7) 0.0105 (7)
Geometric parameters (Å, °)
N2—C7 1.3684 (14) C4—H4 0.9300
N2—C6 1.3899 (14) C9—C10 1.170 (2)
N2—C8 1.4573 (14) C9—C8 1.4641 (19)
N1—C7 1.3284 (14) C3—C2 1.395 (2)
N1—C5 1.3898 (14) C3—H3 0.9300
C5—C4 1.3885 (16) C8—H8A 0.9700
C5—C6 1.4028 (15) C8—H8B 0.9700
C7—N3 1.3505 (15) C1—C2 1.386 (2)
N3—H2N3 0.860 (18) C1—H1 0.9300
N3—H1N3 0.90 (2) C2—H2 0.9300
C6—C1 1.3803 (16) C10—H10 0.9300
C4—C3 1.3856 (19)
C7—N2—C6 106.36 (9) C5—C4—H4 121.2
C7—N2—C8 128.39 (10) C10—C9—C8 176.81 (15)
C6—N2—C8 125.00 (10) C4—C3—C2 121.42 (12)
C7—N1—C5 104.62 (9) C4—C3—H3 119.3
C4—C5—N1 129.79 (11) C2—C3—H3 119.3supplementary materials
sup-5
C4—C5—C6 120.06 (10) N2—C8—C9 111.21 (11)
N1—C5—C6 110.13 (9) N2—C8—H8A 109.4
N1—C7—N3 123.96 (11) C9—C8—H8A 109.4
N1—C7—N2 113.34 (10) N2—C8—H8B 109.4
N3—C7—N2 122.63 (10) C9—C8—H8B 109.4
C7—N3—H2N3 117.1 (11) H8A—C8—H8B 108.0
C7—N3—H1N3 110.8 (13) C6—C1—C2 116.27 (12)
H2N3—N3—H1N3 116.2 (17) C6—C1—H1 121.9
C1—C6—N2 131.60 (11) C2—C1—H1 121.9
C1—C6—C5 122.87 (11) C1—C2—C3 121.79 (12)
N2—C6—C5 105.52 (9) C1—C2—H2 119.1
C3—C4—C5 117.57 (12) C3—C2—H2 119.1
C3—C4—H4 121.2 C9—C10—H10 180.0
C7—N1—C5—C4 −178.09 (12) N1—C5—C6—C1 −178.69 (11)
C7—N1—C5—C6 0.59 (13) C4—C5—C6—N2 179.14 (10)
C5—N1—C7—N3 −178.29 (13) N1—C5—C6—N2 0.31 (12)
C5—N1—C7—N2 −1.34 (14) N1—C5—C4—C3 177.22 (12)
C6—N2—C7—N1 1.56 (14) C6—C5—C4—C3 −1.35 (18)
C8—N2—C7—N1 176.05 (11) C5—C4—C3—C2 1.6 (2)
C6—N2—C7—N3 178.56 (12) C7—N2—C8—C9 −110.26 (14)
C8—N2—C7—N3 −7.0 (2) C6—N2—C8—C9 63.27 (15)
C7—N2—C6—C1 177.81 (13) C10—C9—C8—N2 −27 (3)
C8—N2—C6—C1 3.1 (2) N2—C6—C1—C2 −177.87 (12)
C7—N2—C6—C5 −1.07 (12) C5—C6—C1—C2 0.85 (18)
C8—N2—C6—C5 −175.79 (11) C6—C1—C2—C3 −0.6 (2)
C4—C5—C6—C1 0.14 (18) C4—C3—C2—C1 −0.6 (2)
Hydrogen-bond geometry (Å, °)
D—H···A D—H H···A D···A D—H···A
N3—H1N3···N1i 0.90 (2) 2.36 (2) 3.1823 (18) 153.5 (18)
N3—H2N3···N1ii 0.860 (18) 2.241 (19) 3.0591 (15) 158.6 (15)(2)
Symmetry codes: (i) −x+1, −y, −z+2; (ii) x, −y, z−1/2.supplementary materials
sup-6
Fig. 1supplementary materials
sup-7
Fig. 2supplementary materials
sup-8
Fig. 3